Kulkarni et al. found that EGF and TGF-α, ligands of EGFR, markedly induced COX-2 in a cervical carcinoma cell line, suggesting that deregulated signaling through EGFR is likely to account, at least in part, for increased expression of COX-2 [9]. The gene discussed is EGFR; the disease is cervical carcinoma.